Log In
Print
BCIQ
Print
Print this Print this
 

rVSV HIV-1 gag vaccine

Also known as: rVSV vaccine

  Manage Alerts
Collapse Summary General Information
Company Profectus BioSciences Inc.
DescriptionRecombinant vesicular stomatitis virus (rVSV) vaccine expressing the gag protein of HIV-1 virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infection in treatment-experienced patients; Vaccinate against HIV infection
Regulatory Designation

Partner

Pfizer Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today